MEG3 overexpression has been shown to downregulate miR-96 while upregulating α-tropomyosin 1 (TPM1), which reduced bladder cancer cell viability by increasing apoptotic cell death (Liu et al., 2018). Here, TPM1 is linked to urinary bladder cancer.